Helicobacter pylori is well known to cause gastritis, gastric and duodenal ulcers and gastric cancers. Treatment of H. pylori is usually empirical without susceptibility results available because susceptibility testing usually requires an invasive biopsy for sampling. There is increasing resistance to first and second line empirical antimicrobials worldwide including Australia. A review of susceptibility testing and data from WA will be presented.